DDIT4 and exocrine pancreatic carcinoma: Accordingly, in vivo studies demonstrate the vulnerability of these tumors to antioxidant depletion, while analysis of human tumors shows that decreased REDD1 expression predicts poor patient survival selectively in RAS mutant lung and pancreas carcinomas.